An Alabama community facing pushback from residents over a proposed data center has just made the path easier for other future data center projects. The Bessemer City Council voted Tuesday night in ...
On September 29, 2025, in Sichuan, China, @Lynx's dashcam video captured a traffic accident on a two-way road. In the video, vehicles ahead begin changing lanes as another vehicle approaches from the ...
Residents opposed to data centers at 61st and Colorado voiced their opinion loud and clear both outside city hall and then again inside at the Hobart City Council meeting. Dozens of protesters stood ...
Jacksonville Jaguars rookie Travis Hunter was a highly anticipated player to watch this season as he looked to play both wide receiver and cornerback in the NFL. Coming out of the Colorado Buffaloes, ...
SANTA CRUZ, CA – The Golden State Warriors have signed forward Alex Toohey and guard Pat Spencer to two-way contracts, the team announced today. Toohey, originally selected by the Phoenix Suns with ...
Creating simple data classes in Java traditionally required substantial boilerplate code. Consider how we would represent Java’s mascots, Duke and Juggy: public class JavaMascot { private final String ...
A new analysis by McKinsey & Company projects a massive 3.5-fold increase in the global demand for AI-specific data center capacity by 2030, potentially creating a multi-trillion-dollar market ...
Jay primarily writes news and deals posts for Android Police. Before joining AP, he spent the past several years yammering on about the crazy world of Android for various tech outlets. Besides ...
The Houston Rockets have been atop of headlines throughout the 2025 NBA offseason cycle with big splash acquisitions. From shipping out Jalen Green and Dillon Brooks in exchange for Kevin Durant, to ...
Hedera’s HBAR token staged an early rally but ended Thursday’s session battered, as heavy sell pressure erased gains and broke through critical technical levels. The token climbed 6% from $0.21 to ...
(RTTNews) - Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, Tuesday announced positive top-line results from its Phase 2 VENTURE study of the oral tablet formulation of ...